BioOhio BioBulletin, December 2014Posted by BioOhio on Dec. 18, 2014
Welcome to the December BioBulletin, which is primarily focused on events since there are several planned for early ’15.
In lieu of trivia this month, BioOhio would like to extend warm wishes to you during the holiday season. We are so grateful for all our members and partners who supported us this year. We look forward to continuing our relationship with each of you. Cheers to a prosperous 2015!
January 22 in Mason
BioOhio and Regulatory and Quality Solutions (R&Q) are excited to announce the first in a series of medical device “Regulatory 101″ events.
This session will spotlight risk management and usability engineering, in addition to a broad overview of medical device regulation in the US, Canada, and the European Union.
Each session of the Regulatory 101 Series (4 to be held in 2015) will cover a spotlight topic along with basic regulatory and quality principles. This cost-effective series is geared toward small and start-up companies, junior regulatory and quality staff, medical device development and manufacturing staff, or even seasoned regulatory and quality professionals wishing to brush up on current trends and expectations.
Event details including agenda and registration here.
Bioscience Talent, Workforce & Education Summit and Ohio Biomedical & Pharmaceutical Internship/Career Fair
February 9 in Columbus
BioOhio, in partnership with Southwest Ohio Bioscience Education Consortium and The Ohio Academy of Science, is hosting the Bioscience Talent, Workforce & Education Summit. The goal of this event is to gather the state’s educators, school administrators, career counselors, workforce professionals and industry representatives to discuss the quality, comprehensiveness, and challenges of bioscience education in Ohio.
In support of Ohio’s growing biomedical and pharmaceutical companies, the day will also include the Ohio Biomedical & Pharmaceutical Career/Internship/Co-op Fair, a great opportunity for students, graduates and job seekers to meet hiring companies from around the state. Participating companies will represent the biotech, pharmaceutical, R&D, and medical device industries. Employers, sign up today (pdf) for a spot at the fair and reserve your opportunity to meet new talent!
March 4 in Columbus
The National Heart, Lung, and Blood Institute (NHLBI) Regional Innovation Conference is designed to connect SBIR companies with potential investors and collaborators. It brings together venture capital firms, angel investors, strategic partners, business leaders, entrepreneurs, and SBIR companies.
NHLBI will select SBIR companies from the Midwest region to give ten-minute oral presentations as part of the event agenda, and/or to present their technologies in poster format, available for viewing throughout the conference. The conference will also feature an expert panel of investors, and opportunities for partnering and networking.
NHLBI staff will inform attendees about the NHLBI Office of Translational Alliances and Coordination, the SBIR/STTR program-including eligibility of venture-backed companies to apply-and funding opportunities and resources. NHLBI staff will be available to throughout the event.
This is a free event but registration is required. All details here.
March 10 in Columbus
BioOhio is excited to announce our popular legislative networking event for BioOhio members only in the beautiful Ohio Statehouse. This event provides a unique opportunity to discuss the impact and importance of Ohio’s bioscience companies, research institutions, and educators with state officials and lawmakers. Please join us in representing and advocating for the bioscience industry’s continued growth in Ohio.
Lunch, featuring brief remarks from special guest speakers, will take place 11:30-1 in the Statehouse Atrium. Connect with legislators, their staff, key state officials, and fellow BioOhio members.
BioOhio will help interested members schedule meetings with legislators in their respective districts. To request meetings with legislators, email email@example.com. These meetings will occur throughout the day.
Visit the Advocacy section of our website to learn more about issues in the industry. We’ve also posted a number of helpful links to identify your local representatives.
Check our calendar often for industry/member functions, like these…
Jan. 13 – SBIR/STTR Agency Overview and Proposal Preparation presented by BioEnterprise
Feb. 9-10 – 2015 BIO CEO & Investor Conference – BioOhio members save 20% off the non-BIO member registration rate
Feb. 20 – Big IDEAs for Health presented by OSU Wexner Medical Center
March 10-11 – MidAmerica Healthcare Venture Forum 2015 – BioOhio members are entitled to a discount off the regular event price
March 24-27 – PharmaLink 2015 presented by Xavier Health
Here’s a sample of some of the news from just the past few weeks, starting off with examples of how bioscience continues to flourish in Ohio.
Abeona Therapeutics raised $3.6M to help children suffering from Sanfilippo syndrome. Ganeden Biotech expands distribution in South America as a study shows the synergistic benefits of their ingredients. US Endoscopy announces market release and distribution agreements for two products. Inc. names Cleveland HeartLab the fastest growing private health care company in the Cleveland metro area.
Navidea creates Macrophage Therapeutics to explore therapeutic applications of Manocept. Ohio Northern University receives a $1.2M grant to encourage the entrepreneurial spirit in engineering students. $2M was donated to Summa Health System for cancer research and education. Sustainable food supplies get a boost from research partners Battelle, The Ohio State University and the Ohio Soybean Council.
R&D is once again strong in Ohio as Case Western Reserve University identifies a drug that may heal damaged spines, ClinicalRM announces the start of a clinical trial in Liberia to fight Ebola, Alkermes begins a trial focused on the treatment of schizophrenia, Aerpio Therapeutics completes enrollment into their Phase 2 study, Camargo Pharmaceuticals announces successful completion of a bioequivalence study, Milo Biotechnology is awarded a patent, The Ohio Clinical Trials Collaborative continues to build relationships and N8 Medical announces peer reviews of their technology.
Happy Holidays! Thanks again for your support.
Engage, Bring It!
John F. Lewis, Jr.
BioOhio, President & CEO
(614) 675-3686 x1262
BioOhio BioBulletin, November 2014Posted by BioOhio on Nov. 20, 2014
Welcome to the November BioBulletin,
Thanksgiving trivia this month: The Guinness World Record for the largest pumpkin pie is held where? New Bremen, Ohio! They broke their own record at the New Bremen Pumpkinfest on September 25, 2010 with a pie measuring 20′ in diameter and weighing 3,699 pounds.
Now to what’s cooking in the world of bioscience…
As BioOhio begins to plan for the 2015 Annual Conference, we want your input. Whether you attended or not, please take 1-3 minutes to complete this survey. Your feedback will help us plan for next year’s conference and beyond.
So much is happening around the state we can’t possibly fit it all in the BioBulletin. Here’s just a sample of some of the news posted over the last month.
BioOhio’s John F. Lewis, Jr. speaks with Columbus Business First about the ACA Medical Device Tax, featuring Minimally Invasive Devices, Furniss Corporation, AdvaMed, MDMA and Cardinal Health.
Happy birthday to STATKING Clinical Services, celebrating 25 years! Award winning student entrepreneurs TremorX featured in the Columbus Dispatch. Acquisitions of Ricerca, Axiomed, REU Associates and Devicor Medical Products.
Technology advancements from Cleveland Clinic & Parker Hannifin, AtriCure, NanoLogix, Milo Biotechnology, Siemens, and patents in motion for Microbial Robotics and Freedom Meditech. Expansion & growth continue for CTI Clinical Trial and Consulting Services, Assurex Health, CoverMyMeds and Cardinal Health.
Enable Injections, led by BioOhio Board Member Mike Hooven, launches with CSL Behring, ViewRay receives CE Mark, Great Lakes NeuroTechnologies launches their new app, EpiGlare lands a licensing deal, HealthSpot secures investment from Xerox and partners with RiteAid, and Explorys partners with Mercy Health.
And so much more, including some news we can’t even talk about yet! Keep up with it all at BioOhio.com/blog – your best source for what’s happening in Ohio’s bioscience community.
We are proud to announce that BioOhio has selected G2G Consulting to provide both federal and state government affairs support.
Ohio outperforms even Massachusetts and California in core biopharmaceutical growth ratePosted by BioOhio on Nov. 20, 2014
BioOhio is glad to share some exciting analysis from the Berkshire Atlantic Group that shines a spotlight on Ohio’s bioscience industry.
Since 2007, Ohio has outperformed even the leading biopharmaceutical hubs nationally in core biopharmaceutical employment growth rate. As the tables in the linked document display, Ohio grew 1,066 jobs in biotechnology research and pharmaceutical manufacturing. While this growth trailed California, Massachusetts, and North Carolina in actual numeric growth, Ohio outperformed all states in percentage growth over the same period. When compared to neighboring states such as Pennsylvania and Indiana, Ohio’s performance is striking.
Download the full document from Berkshire Atlantic Group here (pdf).
In determining employment attributable to the drug development, or biopharmaceutical industry, two NAICS classifications were used: Pharmaceutical Manufacturing (NAICS 3254) and Research and Development in Biotechnology (NAICS 541711).
BioOhio also uses NAICS codes to track the bioscience industry, click here to learn more about how the industry is defined. You can also browse the Ohio Bioscience Resource Directory to learn more about companies in specific industry sectors, such as R&D and Pharmaceuticals.
STATKING Clinical Services celebrates 25 years serving the pharmaceutical and medical device industryPosted by BioOhio on Nov. 18, 2014
STATKING, led by President & CEO Dennis King, PhD and Rod Lashley, Executive Vice President, provides clinical trial services for the regulatory approval of novel drug and medical device products. Specific areas of expertise include clinical trial management, protocol development, biostatistics, clinical data management, clinical study monitoring, medical writing, medical monitoring, contract laboratory services, safety reporting and project management.
“Our progress as a CRO is truly a testament to the hard work of many dedicated employees over the past 25 years.” commented King.
“It is truly rewarding to know that we have helped so many companies obtain regulatory approval for their products. We look forward to continuing to be a valued partner for our clients.” added Lashley.
Since opening its doors in 1989, the CRO has provided services on over 300 clinical studies. STATKING has progressed from a biostatistics consulting company to a full service CRO providing a complete solution for the management of clinical trials. The company has provided valued, strategic input to over 100 companies in STATKING’s niche market of emerging pharmaceutical and medical device companies.
“STATKING has been a strong part of Ohio’s bioscience community,” said John F. Lewis, Jr., President & CEO of BioOhio. “They have been one of our most engaged members for as long as I can remember. We look forward to continuing to work together growing Ohio’s bioscience community well into the future.”
You can learn more about STATKING on their website.
BioOhio Annual Conference Road Show comes to Central OhioPosted by BioOhio on Nov. 04, 2014
Join BioOhio in Columbus on November 12 for the powerful finale of the 2014 Annual Conferences!
Highlights include panels on Additive Manufacturing/3D Printing; Transforming Healthcare via Data and IT; Ohio Clinical Trials Collaborative; Integrating Veterinary Applications to accelerate your pharma/device company; Success Stories; and much more.
And to cap it off, the networking reception at 4:00 p.m. will feature music by the BioOhio/Kinnear Road All-Star Band (made up of employees of both BioOhio and TechColumbus.) The band includes:
- Parker MacDonell: acoustic guitar/singer/songwriter, leader of the Advisor Network at TechColumbus, co-founder of Six String Concerts in Columbus, co-founder of Writer Zone Music in Nashville, founder of Fayerweather Records in Los Angeles, Principal at Invergarry Partners, board member and treasurer of the Angel Capital Association
- Phil Maneri: bassist , owner of the Fifth Avenue Fret Shop, Technical Editor of Bass Gear Magazine
- We also have a surprise guest or two joining us on stage from Columbus’ entrepreneurial community. (You’ll never guess!)
Click here for event details, including agenda, registration ($195 for members/$345 for non-members, $50 for the reception only), location and more.